Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Spero Therapeutics, Inc. (SPRO)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
2 Feb 2024
Mahadevia Ankit
Director
Spero Therapeutics, Inc.
(SPRO)
744,997
-7%
63,795
$1.37
$87,399.15
SELL
1 Feb 2024
Shukla Sath
CEO and President, Director, Officer
Spero Therapeutics, Inc.
(SPRO)
1,176,007
-6%
75,994
$1.42
$107,719.22
SELL
1 Feb 2024
HAMED KAMAL
Chief Medical Officer, Officer
Spero Therapeutics, Inc.
(SPRO)
788,117
-3%
28,075
$1.37
$38,462.75
SELL
1 Feb 2024
JOSEPH TAMARA L
Chief Legal Officer, Officer
Spero Therapeutics, Inc.
(SPRO)
531,615
-5%
30,906
$1.37
$42,341.22
SELL
1 Feb 2024
Keutzer Timothy
Chief Operating Officer, Officer
Spero Therapeutics, Inc.
(SPRO)
534,050
-5%
30,971
$1.36
$42,120.56
SELL
13 Sep 2023
HAMED KAMAL
Chief Medical Officer, Officer
Spero Therapeutics, Inc.
(SPRO)
576,461
-6%
39,496
$1.27
$50,159.92
SELL
28 Aug 2023
Mahadevia Ankit
Director
Spero Therapeutics, Inc.
(SPRO)
788,792
-1%
9,040
$1.26
$11,390.40
SELL
28 Aug 2023
Shukla Sath
CEO and President, Director, Officer
Spero Therapeutics, Inc.
(SPRO)
572,500
-1%
6,017
$1.29
$7,747.94
SELL
28 Aug 2023
Keutzer Timothy
Chief Development Officer, Officer
Spero Therapeutics, Inc.
(SPRO)
325,290
-0%
1,854
$1.26
$2,336.04
SELL
28 Aug 2023
JOSEPH TAMARA L
Chief Legal Officer, Officer
Spero Therapeutics, Inc.
(SPRO)
322,790
-0%
1,854
$1.26
$2,336.04
SELL
3 Feb 2023
Mahadevia Ankit
CEO and President, Director, Officer
Spero Therapeutics, Inc.
(SPRO)
797,832
-1%
12,286
$1.81
$22,237.66
SELL
1 Feb 2023
JOSEPH TAMARA L
Chief Legal Officer, Officer
Spero Therapeutics, Inc.
(SPRO)
324,644
-1%
3,394
$1.86
$6,312.84
SELL
1 Feb 2023
Shukla Sath
Chief Financial Officer, Officer
Spero Therapeutics, Inc.
(SPRO)
312,517
-2%
9,504
$1.83
$17,372.36
SELL
1 Feb 2023
Keutzer Timothy
Chief Operating Officer, Officer
Spero Therapeutics, Inc.
(SPRO)
327,144
-1%
3,394
$1.86
$6,312.84
SELL
22 Sep 2022
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
3,985,719
-32%
1,901,796
$2.25
$4,279,611.50
SELL
29 Aug 2022
Shukla Sath
Chief Financial Officer, Officer
Spero Therapeutics, Inc.
(SPRO)
56,064
-9%
6,017
$0.89
$5,377.99
BUY
26 Apr 2022
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
5,321,231
+0%
39,727
$5.24
$207,970.84
BUY
30 Mar 2022
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
5,264,619
+0%
50,000
$8.79
$439,419.97
BUY
14 Mar 2022
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
5,223,498
+0%
23,708
$7.63
$180,797.20
BUY
28 Feb 2022
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
5,192,692
+0%
44,833
$9.53
$427,227.12
BUY
18 Feb 2022
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
5,162,963
+0%
14,828
$9.24
$137,038.90
BUY
31 Jan 2022
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
5,148,135
+2%
125,000
$11.59
$1,448,262.50
BUY
24 Jan 2022
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
5,023,135
+0%
1,599
$10.89
$17,418.07
BUY
18 Jan 2022
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
5,021,536
+0%
48,488
$12.41
$601,963.94
BUY
10 Jan 2022
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
4,973,048
+0%
8,867
$12.93
$114,608.63
BUY
29 Dec 2021
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
4,964,181
+5%
250,493
$15.42
$3,862,898.00
SELL
27 Dec 2021
Mahadevia Ankit
CEO and President, Director, Officer
Spero Therapeutics, Inc.
(SPRO)
144,036
-5%
8,000
$14.58
$116,666.40
BUY
29 Oct 2021
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
4,713,688
+3%
150,000
$17.53
$2,630,175.00
BUY
30 Sep 2021
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
4,563,688
+3%
134,543
$18.65
$2,509,173.00
BUY
13 Sep 2021
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
4,429,145
+1%
46,366
$18.56
$860,547.10
BUY
9 Sep 2021
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
4,382,779
+0%
24,749
$18.50
$457,792.16
BUY
30 Aug 2021
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
4,358,030
+2%
92,687
$18.42
$1,707,519.00
BUY
26 Aug 2021
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
4,265,343
+0%
36,939
$16.67
$615,853.56
BUY
20 Aug 2021
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
4,228,404
+10%
399,195
$15.51
$6,192,042.00
SELL
8 Feb 2021
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
3,829,209
-0%
3,000
$21.74
$65,215.20
SELL
1 Feb 2021
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
3,832,209
-2%
100,000
$19.02
$1,901,987.40
SELL
16 Dec 2020
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
3,932,209
-6%
264,933
$18.80
$4,981,259.50
SELL
16 Dec 2020
Larkin Cristina
Chief Operating Officer, Officer
Spero Therapeutics, Inc.
(SPRO)
1,500
-88%
12,000
$19.00
$228,000.00
SELL
9 Nov 2020
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
4,197,142
-2%
125,900
$13.77
$1,734,071.10
SELL
4 Nov 2020
Aquilo Capital Management, LLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
4,323,042
-3%
174,100
$14.09
$2,452,947.50
SELL
3 Nov 2020
Mahadevia Ankit
CEO and President, Director, Officer
Spero Therapeutics, Inc.
(SPRO)
65,817
-12%
9,507
$14.39
$136,824.73
SELL
23 Oct 2020
Mahadevia Ankit
CEO and President, Director, Officer
Spero Therapeutics, Inc.
(SPRO)
65,817
-0%
20
$14.25
$285.00
SELL
13 Oct 2020
Mahadevia Ankit
CEO and President, Director, Officer
Spero Therapeutics, Inc.
(SPRO)
65,817
-18%
14,472
$14.28
$206,708.73
SELL
8 Sep 2020
Mahadevia Ankit
CEO and President, Director, Officer
Spero Therapeutics, Inc.
(SPRO)
65,817
-1%
774
$14.25
$11,029.73
SELL
7 Jul 2020
Mahadevia Ankit
CEO and President, Director, Officer
Spero Therapeutics, Inc.
(SPRO)
65,817
-4%
3,047
$14.29
$43,551.59
SELL
22 Jun 2020
Mahadevia Ankit
CEO and President, Director, Officer
Spero Therapeutics, Inc.
(SPRO)
65,817
-20%
17,180
$14.30
$245,698.73
BUY
17 Jul 2018
GLAXOSMITHKLINE PLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
1,934,006
+4%
80,000
$12.50
$1,000,000.00
SELL
5 Jul 2018
Sendek Joel
Chief Financial Officer, Officer
Spero Therapeutics, Inc.
(SPRO)
15,181
-11%
2,000
$17.50
$35,000.00
SELL
5 Jul 2018
Larkin Cristina
Chief Operating Officer, Officer
Spero Therapeutics, Inc.
(SPRO)
1,500
-72%
4,000
$17.50
$70,000.00
SELL
5 Jul 2018
Mahadevia Ankit
See Remarks, Director, Officer
Spero Therapeutics, Inc.
(SPRO)
66,917
-6%
4,676
$17.63
$82,436.73
BUY
6 Nov 2017
Goyal Vikas
Director
Spero Therapeutics, Inc.
(SPRO)
1,854,006
+30%
428,571
$14.00
$5,999,994.00
BUY
6 Nov 2017
GLAXOSMITHKLINE PLC
10% Owner
Spero Therapeutics, Inc.
(SPRO)
1,854,006
+30%
428,571
$14.00
$5,999,994.00
BUY
6 Nov 2017
Breum Casper
Director
Spero Therapeutics, Inc.
(SPRO)
1,091,774
+24%
214,285
$14.00
$2,999,990.00
BUY
6 Nov 2017
Sendek Joel
Chief Financial Officer, Officer
Spero Therapeutics, Inc.
(SPRO)
15,181
+49%
5,000
$14.00
$70,000.00
BUY
6 Nov 2017
FORMELA JEAN FRANCOIS
Director
Spero Therapeutics, Inc.
(SPRO)
2,408,128
+21%
428,571
$14.00
$5,999,994.00
BUY
6 Nov 2017
Larkin Cristina
Chief Operating Officer, Officer
Spero Therapeutics, Inc.
(SPRO)
1,500
+100%
1,500
$14.00
$21,000.00
Home